cameron
studi
object
compar
analges
efficaci
advers
effect
oral
prednisoloneacetaminophen
oral
indomethacinacetaminophen
combin
therapi
treatment
acut
goutlik
arthriti
patient
present
emerg
depart
ed
method
doubleblind
random
control
studi
univers
hospit
emerg
depart
ed
new
territori
hong
kong
patient
older
year
present
februari
june
clinic
diagnosi
goutlik
arthriti
random
receiv
either
oral
prednisoloneacetaminophen
oral
indomethacinacetaminophen
combin
therapi
primari
outcom
measur
pain
score
time
resolut
symptom
sign
advers
effect
secondari
outcom
measur
need
addit
acetaminophen
relaps
rate
result
patient
random
patient
indomethacin
group
patient
prednisolon
group
baselin
characterist
includ
pain
score
similar
group
treatment
group
similar
decreas
pain
score
ed
mean
rate
decreas
pain
score
activ
indomethacin
sd
mm
per
day
prednisolon
sd
mm
per
day
mean
differ
mmday
confid
interv
mmday
although
differ
statist
signific
time
differ
mean
pain
score
greater
mm
therefor
unclear
whether
differ
clinic
signific
mean
total
dose
acetaminophen
consum
prednisolon
group
significantli
indomethacin
group
mean
g
rang
g
versu
mean
g
rang
g
twentynin
patient
indomethacin
group
patient
prednisolon
group
experienc
advers
effect
commonest
advers
effect
indomethacin
group
nausea
indigest
epigastr
pain
dizzi
gastrointestin
bleed
none
patient
prednisolon
group
develop
gastrointestin
bleed
relaps
rate
group
similar
conclus
treatment
acut
goutlik
arthriti
oral
prednisoloneacetaminophen
combin
effect
oral
indomethacinacetaminophen
combin
reliev
pain
associ
fewer
advers
effect
acut
gouti
arthriti
crystalinduc
inflamm
joint
primarili
affect
middleag
elderli
adult
commonest
caus
inflammatori
joint
diseas
men
older
year
estim
overal
preval
unit
kingdom
per
men
affect
commonli
women
diagnosi
acut
gout
typic
made
clinic
presenc
rapid
onset
sever
pain
swell
erythema
affect
joint
definit
demonstr
presenc
neg
birefring
uric
acid
crystal
aspir
joint
fluid
diagnosi
often
made
absenc
joint
aspir
procedur
pain
poorli
toler
patient
declin
other
sometim
difficult
inconveni
perform
busi
emerg
depart
ed
treatment
patient
inconsist
evidencebas
guidelin
support
clinic
manag
lack
gout
increasingli
preval
condit
worldwid
creat
heavi
econom
burden
import
oral
nonsteroid
antiinflammatori
drug
nsaid
administ
high
dose
recommend
firstlin
agent
manag
gout
may
contraind
gastrointestin
hemorrhag
renal
failur
oral
colchicin
may
effect
nsaid
limit
toxic
higher
dose
intraarticular
corticosteroid
may
also
administ
monoarticular
diseas
intramuscular
corticosteroid
podagra
small
control
studi
compar
oral
nsaid
intraarticular
intramuscular
steroid
suggest
nsaid
effect
steroid
treatment
acut
gout
howev
nsaid
signific
rate
advers
effect
includ
gastric
irrit
gastrointestin
hemorrhag
renal
failur
although
steroid
caus
sever
advers
event
taken
high
dose
long
period
appear
advers
effect
taken
low
moder
dose
short
period
gastrointestin
advers
effect
also
appear
less
sever
nsaid
longterm
effect
osteoporosi
muscl
wast
relev
acut
gout
treatment
oral
nsaid
compar
oral
steroid
manag
acut
gout
object
studi
compar
efficaci
advers
effect
oral
indomethacinacetaminophen
oral
prednisoloneacetaminophen
combin
therapi
treatment
patient
present
ed
clinic
diagnosi
acut
goutlik
arthriti
prospect
random
doubleblind
control
studi
analges
efficaci
advers
effect
oral
prednisoloneacetaminophen
oral
indomethacin
acetaminophen
combin
compar
patient
present
ed
clinic
diagnosi
acut
gouti
arthriti
figur
ethic
approv
obtain
local
institut
research
ethic
committe
inform
written
consent
obtain
patient
ed
princ
wale
hospit
teach
hospit
new
territori
hong
kong
receiv
new
patient
per
annum
admit
hospit
hospit
serv
popul
approxim
million
gout
respons
patient
visit
per
day
princ
wale
hospit
ed
patient
admit
ed
observ
ward
hospit
ward
mainli
patient
elderli
lack
social
support
patient
older
year
acut
arthriti
suggest
gout
present
ed
design
period
research
staff
duti
pm
monday
friday
februari
june
consid
enrol
patient
includ
clinic
diagnosi
acut
arthriti
suggest
gout
defin
presenc
pain
warmth
joint
present
within
day
onset
pain
also
follow
metatarsalphalang
joint
involv
knee
ankl
joint
involv
aspir
contain
crystal
typic
gouti
arthriti
either
gouti
tophi
present
previou
joint
aspir
confirm
diagnosi
gout
patient
exclud
clinic
suspicion
sepsi
joint
diseas
followup
imposs
lack
transport
lack
telephon
contact
signific
comorbid
would
interfer
assess
patient
dementia
confus
activ
gastrointestin
symptom
renal
insuffici
serum
creatinin
level
greater
moll
bleed
disord
allergi
studi
drug
joint
aspir
exclud
diagnosi
gout
take
warfarin
alreadi
known
topic
acut
gouti
arthriti
typic
treat
nonsteroid
antiinflammatori
agent
though
prednison
also
recommend
rel
efficaci
unknown
efficaci
advers
effect
oral
prednisolon
oral
indomethacin
treatment
acut
goutlik
arthriti
emerg
depart
patient
random
control
trial
treatment
exhibit
similar
efficaci
advers
effect
common
patient
given
indomethacin
includ
gastrointestin
bleed
short
cours
prednisolon
least
effect
indomethacin
may
safer
often
possibl
definit
separ
gout
septic
arthriti
clinic
ground
alon
studi
sepsi
consid
like
patient
temperatur
greater
chill
rigor
wound
near
affect
joint
histori
immunosuppress
erythemat
track
along
lymphat
vessel
vein
affect
limb
lymphadenopathi
histori
septic
arthriti
patient
alloc
randomnumb
tabl
gener
statview
window
version
abacu
concept
sa
institut
inc
cari
nc
random
alloc
sequenc
implement
number
seal
envelop
sequenc
conceal
intervent
assign
nurs
clinic
respons
open
precod
envelop
detail
drug
random
number
oral
prepar
indomethacin
mg
acetaminophen
mg
prednisolon
mg
ident
placebo
prepack
place
insid
envelop
diclofenac
prepar
solut
mgml
placebo
normal
salin
solut
solut
prepar
ed
nurs
involv
administr
analgesia
assess
patient
treatment
advers
effect
code
broken
physician
nurs
clinic
duti
concern
sever
advers
effect
research
nurs
nonclin
duti
patient
blind
medic
indomethacin
group
patient
initi
receiv
diclofenac
ml
mg
intramuscularli
indomethacin
mg
oral
acetaminophen
g
oral
tablet
prednisolonelik
placebo
oral
observ
minut
patient
given
prescript
indomethacin
mg
oral
everi
hour
day
follow
indomethacin
mg
everi
hour
anoth
day
tablet
prednisolonelik
placebo
day
acetaminophen
g
everi
hour
requir
prednisolon
group
patient
initi
receiv
intramuscular
placebo
inject
ml
prednisolon
mg
time
mg
oral
acetaminophen
g
tablet
oral
indomethacinlik
placebo
tablet
oral
observ
minut
patient
given
prescript
indomethacinlik
placebo
prednisolon
mg
oral
per
day
acetaminophen
g
everi
hour
requir
acetaminophen
intramuscular
inject
given
accord
common
local
practic
mani
patient
hong
kong
believ
symptomat
relief
faster
inject
administ
physician
duti
free
give
extra
dose
altern
analges
clinic
requir
document
assess
includ
demograph
data
assess
schedul
interv
pain
score
rest
activ
occurr
advers
effect
time
symptom
resolut
pain
score
assess
visual
analogu
scale
absenc
pain
sever
pain
patient
ever
experienc
number
horizont
visual
analogu
pain
score
use
baselin
measur
subsequ
interv
first
inject
pain
score
advers
effect
record
everi
minut
hour
drug
administr
patient
awar
previou
score
stage
record
research
staff
contact
patient
telephon
hour
physic
assess
patient
admit
observ
ward
day
also
telephon
day
unless
symptom
resolv
patient
record
data
daili
day
home
type
number
durat
sever
advers
effect
document
specif
question
advers
event
ask
day
collect
advers
event
data
eg
experi
nausea
today
primari
clinic
outcom
measur
pain
relief
measur
chang
pain
score
rest
activ
advers
event
chang
score
absolut
valu
measur
activ
involv
research
nurs
gentli
move
joint
involv
standard
manner
assess
pain
advers
event
assess
number
durat
sever
applic
secondari
outcom
measur
time
complet
resolut
pain
stiff
joint
swell
supplementari
acetaminophen
relaps
rate
data
collect
ceas
day
nonresolut
symptom
recurr
symptom
time
regard
treatment
failur
data
analyz
intentiontotreat
basi
statist
analys
involv
test
use
statview
window
version
statist
analysi
softwar
abacu
concept
sa
institut
consid
statist
signific
pain
score
time
data
conform
gaussian
distribut
nonparametr
test
use
analyz
data
baselin
characterist
treatment
analyz
use
test
mannwhitney
u
test
regress
line
indic
chang
visual
analog
scale
pain
score
time
found
slope
therefor
summari
measur
patient
distribut
coeffici
follow
normal
distribut
mean
slope
coeffici
treatment
group
compar
analyz
use
test
previou
studi
shown
differ
visual
analog
pain
score
less
mm
unlik
clinic
relev
therefor
unless
upper
limit
confid
interv
ci
less
mm
assum
result
inconclus
detect
clinic
signific
differ
mean
pain
score
group
mm
sd
mm
estim
power
signific
level
patient
requir
group
studi
period
patient
present
clinic
diagnosi
probabl
acut
gout
exclud
acut
gastroduoden
ulcer
trauma
serum
creatinin
level
greater
nmoll
bleed
disord
histori
advers
reaction
nsaid
suspicion
infecti
caus
remain
patient
random
patient
indomethacin
group
patient
prednisolon
group
figur
demograph
baselin
characterist
group
similar
tabl
signific
differ
initi
mean
pain
score
rest
activ
treatment
group
five
patient
prednisolon
group
patient
indomethacin
group
agre
allow
joint
aspir
posit
urat
crystal
neg
bacteri
cultur
ed
phase
rate
decreas
mean
pain
score
time
rest
activ
figur
similar
group
mean
rate
decreas
pain
score
rest
indomethacin
sd
mm
per
hour
prednisolon
sd
mm
per
hour
mean
differ
mmhour
ci
mmhour
mean
rate
decreas
pain
score
activ
indomethacin
sd
mm
per
hour
prednisolon
sd
mm
per
hour
mean
differ
mmhour
ci
mmhour
followup
phase
rate
decreas
mean
pain
score
time
rest
activ
figur
greater
prednisolon
group
indomethacin
group
mean
rate
decreas
pain
score
rest
indomethacin
sd
mm
per
day
prednisolon
sd
mm
per
day
mean
differ
mmday
ci
mmday
mean
rate
decreas
pain
score
activ
indomethacin
sd
mm
per
day
prednisolon
sd
mm
per
day
mean
differ
mmday
ci
mmday
although
differ
activ
statist
signific
time
differ
mean
pain
score
greater
mm
day
last
followup
day
end
point
reach
group
treatment
group
show
improv
joint
swell
stiff
differ
improv
group
indomethacin
group
patient
experienc
advers
effect
compar
patient
prednisolon
group
tabl
nausea
indigest
epigastr
pain
dizzi
significantli
common
indomethacin
group
prednisolon
group
common
advers
effect
steroid
group
dri
mouth
dizzi
seven
patient
advers
effect
seriou
enough
requir
treatment
hospit
admiss
indomethacin
group
five
patient
develop
gastrointestin
bleed
age
rang
year
four
admit
hospit
fifth
refer
outpati
clinic
case
studi
medic
stop
upper
gastrointestin
endoscopi
perform
patient
acut
gastric
ulcer
receiv
adrenalin
inject
activ
bleed
patient
gastroduoden
ulcer
patient
develop
cardiovascular
shock
ulcer
heal
treatment
patient
group
consum
acetaminophen
day
mean
total
dose
acetaminophen
consum
prednisolon
group
significantli
consum
indomethacin
group
mean
g
rang
g
versu
mean
g
rang
g
overal
within
day
patient
indomethacin
group
relaps
reattend
treatment
compar
patient
prednisolon
group
fifteen
patient
prednisolon
group
requir
altern
medic
pain
relief
compar
patient
indomethacin
group
diagnosi
made
clinic
impress
joint
aspir
perform
patient
howev
routin
clinic
practic
major
patient
present
goutlik
arthriti
treat
clinic
without
joint
aspir
unless
high
index
suspicion
septic
arthriti
atyp
featur
rel
small
sampl
size
may
allow
us
detect
small
differ
pain
score
sampl
size
base
estim
clinic
signific
differ
safeti
aspect
primari
aspect
studi
power
evalu
safeti
possibl
larger
number
figur
intervent
given
patient
random
studi
group
patient
prednisolon
group
would
also
signific
advers
event
final
use
placebo
inject
artifici
standard
practic
use
placebo
import
ensur
complet
blind
introduc
problem
artifici
extent
limit
applic
clinic
practic
clear
first
doubleblind
random
placebocontrol
studi
compar
commonli
use
inexpens
easili
avail
indomethacin
prednisolon
treatment
acut
goutlik
arthriti
result
indic
treatment
acut
goutlik
arthriti
commonli
prescrib
dose
frequenc
prednisolon
indomethacin
produc
similar
pain
relief
howev
patient
prednisolon
group
took
significantli
acetaminophen
indomethacin
group
adjunct
pain
relief
prednisolon
supplement
acetaminophen
may
effect
indomethacin
reliev
pain
patient
take
prednisolon
experienc
far
fewer
seriou
advers
effect
compar
patient
take
indomethacin
although
nsaid
recommend
firstlin
therapi
acut
gouti
arthriti
studi
role
steroid
treatment
condit
small
preliminari
studi
suggest
short
cours
oral
corticosteroid
therapi
could
use
effect
acut
gout
nsaid
contraind
subsequ
anoth
small
studi
patient
singl
intramuscular
inject
betamethason
intraven
methylprednisolon
oral
diclofenac
result
prompt
equal
improv
glucocorticoid
therapi
well
toler
sampl
size
small
advers
effect
report
oral
corticosteroid
use
anoth
small
studi
patient
safeti
effect
intramuscular
triamcinolon
treatment
acut
gout
also
note
review
articl
kim
et
al
report
therapi
avail
manag
acut
gout
includ
corticotropin
corticosteroid
colchicin
nsaid
associ
signific
advers
event
howev
studi
found
case
upper
gastrointestin
bleed
group
treat
prednisolon
wherea
patient
indomethacin
group
develop
upper
gastrointestin
bleed
although
none
patient
die
advers
effect
occurr
upper
gastrointestin
bleed
especi
elderli
caus
signific
morbid
pain
score
rest
activ
follow
similar
pattern
trend
improv
prednisolon
indomethacin
group
howev
patient
prednisolon
group
use
slightli
acetaminophen
suggest
prednisolon
alon
may
enough
reliev
pain
associ
diseas
studi
compar
inhibitor
nsaid
found
former
similar
compar
efficaci
better
toler
howev
inhibitor
expens
less
access
gener
popul
even
import
concern
cardiovascular
safeti
inhibitor
use
corticosteroid
treatment
acut
gout
also
known
effect
corticosteroid
use
clinic
treatment
larg
varieti
condit
rang
allerg
ectop
diseas
asthma
connect
tissu
diseas
inflammatori
condit
analges
recommend
usual
rank
corticosteroid
second
line
treatment
wherea
nsaid
usual
tri
first
sever
possibl
reason
physician
reluct
use
corticosteroid
physician
experi
nsaid
treatment
gout
addit
corticosteroid
receiv
bad
public
term
numer
longterm
advers
effect
cush
syndrom
osteoporosi
diabet
mellitu
hypertens
recent
report
avascular
necrosi
use
highdos
methylprednisolon
treatment
sever
acut
respiratori
syndrom
anoth
vivid
exampl
result
line
epidemiolog
report
acut
gouti
arthriti
commonli
affect
elderli
patient
risk
seriou
gastrointestin
toxic
nsaid
higher
age
group
accord
find
studi
recommend
moder
dose
oral
prednisolon
supplement
oral
acetaminophen
consid
firstlin
therapi
treatment
acut
gout
supervis
editor
richard
c
dart
md
phd
author
contribut
cym
idea
studi
overseen
entir
plan
execut
analysi
prepar
articl
pac
obtain
approv
guarantor
work
itfc
pac
thr
particip
plan
execut
analysi
thr
prepar
statist
analysi
cym
wrote
first
draft
articl
author
contribut
final
version
cym
take
respons
paper
whole
fund
support
author
report
studi
receiv
outsid
fund
support
